《亞洲市況》日經半日續跌582點或2.2% 圓匯114.62
俄羅斯承認烏克蘭東部兩個親俄地區獨立,俄羅斯總統普京向下令軍隊進入頓巴斯地區執行「維和任務」;另據《彭博通訊社》報道,聯合國安全理事會於紐約時間周一(21日)晚上9時召開緊急會議,道指期貨現跌約500點。日經指數承接過去三個交易日跌勢,今早(22日)大幅低開395點後,早市跌幅擴大,半日跌582點或2.17%,近低收報26,327,逼近今年1月下旬所創逾一年低位。美元兌日圓報114.62。
權重股拖低大市,迅銷及軟銀集團跌1.5%至2.4%、半導體巨擘Screen集團、Advantest Corp、Sumco挫5.4%至6%、另主要車股豐田、日產及三菱汽車跌2.4%至4.7%、五十鈴及萬事得更各跌約5%。主要金融股走低,Resona控股微跌0.3%、三菱日聯、大和、野村、瑞穗及三井住友跌0.9%至1.8%。
台灣鴻海科技旗下夏普(SHARP)繼上日挫10.1%後,半日續跌7.4%,其上周五(18日)宣布,經董事會通過,要將現在保有的20%股份的大型液晶面板生產公司的SDP完全子公司化。
第一三共飆9.8%,阿斯利康(AZN.US)與第一三共近日公布了關鍵3期DESTINY-Breast04試驗(NCT03734029)的陽性高水平結果,數據顯示:在HER2低表達(定義為:IHC 1+或IHC 2+/ISH-)、不可切除性和/或轉移性乳腺癌患者中,無論激素受體(HR)狀態如何,與醫生選擇的化療相比,Enhertu(trastuzumab deruxtecan)治療使無進展生存期(PFS)和總生存期(OS)取得了統計學顯著和臨床意義的改善。Enhertu是一款HER2靶向抗體偶聯藥物(ADC),由阿斯利康與第一三共合作開發。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.